Journal article · 2026 · Open access

Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes

Stefano Zineddu, Athi Welsh, Çağrı Özsan, Anson Kwok‐Hei Chau, David R. Husbands, Kiera Robinson, Luigi Messori A, Angelo Frei

Journal of Medicinal Chemistry · Published 12 November 2026 · DOI 10.1021/acs.jmedchem.6c02512

Open PDFView at the publisherCite this paper

In brief

“Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes” is a 2026 journal article by Stefano Zineddu and 7 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Medicinal Chemistry.

Citations
0
References
78
Authors
8

Abstract

Antimicrobial resistance (AMR) represents a major global health challenge, compounded by a limited antibiotic discovery pipeline and restricted chemical diversity among clinically used antibiotics. Metal-based complexes offer promising antimicrobial agents owing to their structural diversity and unique modes of action. Here, we report the synthesis and biological evaluation of two combinatorial libraries comprising 176 novel ruthenium(II) p-cymene (RuCy) and iridium(III) Cp* (IrCp) N^O-Schiff-base complexes. Syntheses used a robust three-step, room-temperature methodology, with automated LC−MS characterization enabling Direct-to-Biology screening. Against Staphylococcus aureus, 50−80% of compounds inhibited growth, whereas no significant activity was observed against Escherichia coli. Three leads exhibited MICs of 1.56−12.5 μM against Gram-positive pathogens, therapeutic indices exceeding 15, and negligible haemolysis. Mechanistic studies suggest that IrCp-B5, incorporating the ligand (E)-2-bromo-4-chloro-6-(((naphthalen-2-ylmethyl)imino)methyl)phenol, disrupts membrane associated processes, while RuCy-J3, incorporating (E)-1-((cyclohexylimino)methyl)naphthalen-2-ol, targets intracellular DNA-related pathways. This work demonstrates the utility of Direct-to-Biology approaches for accelerated antimicrobial lead identification and prioritization.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zineddu, S., Welsh, A., Özsan, Ç., Chau, A. K., Husbands, D. R., Robinson, K., A, L. M., & Frei, A. (2026). Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02512

MLA 9

Zineddu, Stefano, et al. “Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02512.

Chicago

Zineddu, Stefano, Athi Welsh, Çağrı Özsan, Anson Kwok‐Hei Chau, David R. Husbands, Kiera Robinson, Luigi Messori A, and Angelo Frei. 2026. “Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02512.

Harvard

Zineddu, S. et al. (2026) ‘Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02512.

IEEE

S. Zineddu et al., “Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02512.

BibTeX

@article{zineddu2026combinatorial,
  title     = {{Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes}},
  author    = {Zineddu, Stefano and Welsh, Athi and Özsan, Çağrı and Chau, Anson Kwok‐Hei and Husbands, David R. and Robinson, Kiera and A, Luigi Messori and Frei, Angelo},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  doi       = {10.1021/acs.jmedchem.6c02512},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c02512}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties

  • ruthenium(II) complexes
  • iridium(III) complexes
  • p-cymene ruthenium complexes
  • cyclopentadienyl iridium complexes
  • metal-based antimicrobials
  • antimicrobial resistance
  • Staphylococcus aureus
  • Escherichia coli

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Zineddu, S., Welsh, A., Özsan, Ç., Chau, A. K., Husbands, D. R., Robinson, K., A, L. M., & Frei, A. (2026). Combinatorial Synthesis and Direct-to-Biology Antibacterial Evaluation of Ruthenium(II) and Iridium(III) N^O -Schiff−Base Complexes. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02512

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Medicinal Chemistry: sign in and open the PDF from this page.

Who wrote this paper?

Stefano Zineddu, Athi Welsh, Çağrı Özsan, Anson Kwok‐Hei Chau, David R. Husbands, Kiera Robinson, Luigi Messori A, Angelo Frei.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c02512, permanently at https://doi.org/10.1021/acs.jmedchem.6c02512. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.